Werbung
Werbung
Vereinigte Staaten von Amerika Aktien
Führende Pharmazeutika Industrie
Siehe:
Übersicht
Leistung
50 Ergebnisse
| Ticker | Name | Letzter | Änderung | Veränderung (%) | Volumen | Markt Cap | KGV | EPS | Sektor | Branche |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | Lilly(Eli) & Co | $748.00 | -1.92 | -0.26% | 113.62K | 710.09B | 73.37 | 9.25 | Gesundheitstechnologie | Führende Pharmazeutika |
| JNJ | Johnson & Johnson | $155.14 | -0.36 | -0.23% | 285.26K | 373.52B | 15.04 | 6.91 | Gesundheitstechnologie | Führende Pharmazeutika |
| ABBV | Abbvie Inc | $176.95 | 5.22 | 3.04% | 489.50K | 312.70B | 15.35 | 2.88 | Gesundheitstechnologie | Führende Pharmazeutika |
| MRK | Merck & Co Inc | $99.16 | -0.70 | -0.70% | 621.56K | 250.84B | 16.19 | 4.77 | Gesundheitstechnologie | Führende Pharmazeutika |
| PFE | Pfizer Inc. | $25.63 | 0.50 | 1.99% | 1.26M | 145.24B | 9.61 | 0.74 | Gesundheitstechnologie | Führende Pharmazeutika |
| BMY | Bristol-Myers Squibb Co. | $58.87 | 0.64 | 1.10% | 268.63K | 119.40B | 48.05 | -3.59 | Gesundheitstechnologie | Führende Pharmazeutika |
| VRTX | Vertex Pharmaceuticals, Inc. | $450.72 | 0.35 | 0.08% | 34,405 | 116.07B | N/A | -1.99 | Gesundheitstechnologie | Führende Pharmazeutika |
| REGN | Regeneron Pharmaceuticals, Inc. | $738.00 | -6.50 | -0.87% | 36,037 | 81.10B | 18.93 | 40.41 | Gesundheitstechnologie | Führende Pharmazeutika |
| ZTS | Zoetis Inc - Class A | $176.98 | 0.27 | 0.15% | 43,992 | 79.02B | 30.41 | 5.32 | Gesundheitstechnologie | Führende Pharmazeutika |
| ALNY | Alnylam Pharmaceuticals Inc | $244.81 | -1.99 | -0.81% | 11,894 | 31.58B | N/A | -2.62 | Gesundheitstechnologie | Führende Pharmazeutika |
| BIIB | Biogen Inc | $157.84 | -0.17 | -0.11% | 50,872 | 23.00B | 10.01 | 11.07 | Gesundheitstechnologie | Führende Pharmazeutika |
| UTHR | United Therapeutics Corp | $372.96 | 5.60 | 1.52% | 6,891.00 | 16.65B | 15.95 | 22.77 | Gesundheitstechnologie | Führende Pharmazeutika |
| VTRS | Viatris Inc | $13.37 | 0.24 | 1.83% | 261.33K | 15.96B | 4.72 | -0.74 | Gesundheitstechnologie | Führende Pharmazeutika |
| RPRX | Royalty Pharma plc - Class A | $26.41 | 0.01 | 0.04% | 78,928 | 15.14B | 6.22 | 1.93 | Gesundheitstechnologie | Führende Pharmazeutika |
| INCY | Incyte Corp. | $71.70 | 1.31 | 1.86% | 52,540 | 13.81B | N/A | 0.14 | Gesundheitstechnologie | Führende Pharmazeutika |
| INSM | Insmed Inc | $73.12 | -0.69 | -0.94% | 59,102 | 13.08B | N/A | -5.55 | Gesundheitstechnologie | Führende Pharmazeutika |
| NBIX | Neurocrine Biosciences, Inc. | $125.67 | 0.67 | 0.54% | 53,263 | 12.72B | 31.49 | 3.73 | Gesundheitstechnologie | Führende Pharmazeutika |
| CTLT | Catalent Inc. | $60.95 | 1.29 | 2.16% | 149.81K | 11.06B | N/A | -2.26 | Gesundheitstechnologie | Führende Pharmazeutika |
| SRPT | Sarepta Therapeutics Inc | $114.24 | 3.74 | 3.38% | 24,213 | 10.91B | 90.12 | 1.25 | Gesundheitstechnologie | Führende Pharmazeutika |
| EXEL | Exelixis Inc | $35.62 | 0.79 | 2.27% | 75,834 | 10.17B | 22.37 | 1.56 | Gesundheitstechnologie | Führende Pharmazeutika |
| ROIV | Roivant Sciences Ltd | $12.52 | 0.70 | 5.92% | 391.83K | 9.26B | N/A | 5.65 | Gesundheitstechnologie | Führende Pharmazeutika |
| ITCI | Intra-Cellular Therapies Inc | $85.66 | 0.21 | 0.25% | 17,247 | 9.08B | N/A | -0.87 | Gesundheitstechnologie | Führende Pharmazeutika |
| RGEN | Repligen Corp. | $142.58 | 0.82 | 0.58% | 25,921 | 7.99B | 91.04 | -0.37 | Gesundheitstechnologie | Führende Pharmazeutika |
| JAZZ | Jazz Pharmaceuticals plc | $126.69 | 1.59 | 1.27% | 24,957 | 7.66B | 7.19 | 7.10 | Gesundheitstechnologie | Führende Pharmazeutika |
| MDGL | Madrigal Pharmaceuticals Inc | $347.35 | 18.11 | 5.50% | 24,213 | 7.58B | N/A | -25.08 | Gesundheitstechnologie | Führende Pharmazeutika |
| CORT | Corcept Therapeutics Inc | $57.50 | 1.58 | 2.83% | 19,692 | 6.02B | 41.13 | 1.26 | Gesundheitstechnologie | Führende Pharmazeutika |
| VKTX | Viking Therapeutics Inc | $52.60 | 0.97 | 1.88% | 89,419 | 5.86B | N/A | -0.93 | Gesundheitstechnologie | Führende Pharmazeutika |
| CYTK | Cytokinetics Inc | $49.09 | 1.42 | 2.98% | 54,116 | 5.79B | N/A | -5.38 | Gesundheitstechnologie | Führende Pharmazeutika |
| TGTX | TG Therapeutics Inc | $35.05 | 0.50 | 1.45% | 104.37K | 5.46B | N/A | -0.10 | Gesundheitstechnologie | Führende Pharmazeutika |
| IONS | Ionis Pharmaceuticals Inc | $33.98 | 0.04 | 0.12% | 75,531 | 5.37B | N/A | -2.44 | Gesundheitstechnologie | Führende Pharmazeutika |
| CRNX | Crinetics Pharmaceuticals Inc | $56.05 | -0.98 | -1.72% | 29,903 | 5.20B | N/A | -3.73 | Gesundheitstechnologie | Führende Pharmazeutika |
| ALKS | Alkermes plc | $28.78 | 1.08 | 3.90% | 90,110 | 4.66B | 15.32 | 1.95 | Gesundheitstechnologie | Führende Pharmazeutika |
| BHVN | Biohaven Ltd | $45.59 | 0.40 | 0.89% | 23,659 | 4.61B | N/A | -9.35 | Gesundheitstechnologie | Führende Pharmazeutika |
| RARE | Ultragenyx Pharmaceutical Inc. | $47.24 | 1.22 | 2.65% | 23,776 | 4.36B | N/A | -6.47 | Gesundheitstechnologie | Führende Pharmazeutika |
| PBH | Prestige Consumer Healthcare Inc | $84.78 | 0.64 | 0.76% | 4,411.00 | 4.19B | 20.24 | 4.11 | Gesundheitstechnologie | Führende Pharmazeutika |
| OGN | Organon & Co. | $15.28 | 0.39 | 2.62% | 108.93K | 3.94B | 3.90 | 5.04 | Gesundheitstechnologie | Führende Pharmazeutika |
| PRGO | Perrigo Company plc | $28.07 | 0.99 | 3.66% | 52,733 | 3.83B | 10.77 | -1.17 | Gesundheitstechnologie | Führende Pharmazeutika |
| APLS | Apellis Pharmaceuticals Inc | $30.76 | 3.01 | 10.85% | 118.45K | 3.83B | N/A | -2.03 | Gesundheitstechnologie | Führende Pharmazeutika |
| IBRX | ImmunityBio Inc | $5.10 | 0.07 | 1.29% | 138.73K | 3.55B | N/A | -0.92 | Gesundheitstechnologie | Führende Pharmazeutika |
| MLTX | MoonLake Immunotherapeutics - Class A | $54.33 | 2.47 | 4.76% | 5,283.00 | 3.12B | N/A | -1.29 | Gesundheitstechnologie | Führende Pharmazeutika |
| PTCT | PTC Therapeutics Inc | $43.18 | 0.29 | 0.68% | 11,518 | 3.33B | N/A | -5.94 | Gesundheitstechnologie | Führende Pharmazeutika |
| AGIO | Agios Pharmaceuticals Inc | $55.67 | 0.13 | 0.23% | 12,400 | 3.17B | N/A | 11.36 | Gesundheitstechnologie | Führende Pharmazeutika |
| XENE | Xenon Pharmaceuticals Inc | $41.19 | 1.39 | 3.49% | 7,220.00 | 3.14B | N/A | -2.82 | Gesundheitstechnologie | Führende Pharmazeutika |
| VCEL | Vericel Corp | $59.14 | 2.43 | 4.29% | 10,430 | 2.92B | 874.67 | 0.06 | Gesundheitstechnologie | Führende Pharmazeutika |
| FOLD | Amicus Therapeutics Inc | $9.67 | 0.17 | 1.79% | 48,068 | 2.89B | N/A | -0.34 | Gesundheitstechnologie | Führende Pharmazeutika |
| ACAD | Acadia Pharmaceuticals Inc | $16.37 | 0.19 | 1.17% | 65,993 | 2.72B | 21.50 | 0.78 | Gesundheitstechnologie | Führende Pharmazeutika |
| AMRX | Amneal Pharmaceuticals Inc - Class A | $8.38 | 0.07 | 0.78% | 61,184 | 2.62B | 15.69 | -0.68 | Gesundheitstechnologie | Führende Pharmazeutika |
| CPRX | Catalyst Pharmaceuticals Inc | $21.47 | 0.35 | 1.66% | 21,108 | 2.56B | 11.14 | 1.18 | Gesundheitstechnologie | Führende Pharmazeutika |
| SLNO | Soleno Therapeutics Inc | $57.73 | 3.10 | 5.67% | 21,086 | 2.49B | N/A | -3.32 | Gesundheitstechnologie | Führende Pharmazeutika |
| IDYA | Ideaya Biosciences Inc | $26.75 | 0.15 | 0.56% | 26,893 | 2.31B | N/A | -2.33 | Gesundheitstechnologie | Führende Pharmazeutika |